Amyloid β-Protein (25-35) trifluoroacetate salt
Amyloid β-Protein (25-35) trifluoroacetate salt structure
|
Common Name | Amyloid β-Protein (25-35) trifluoroacetate salt | ||
|---|---|---|---|---|
| CAS Number | 131602-53-4 | Molecular Weight | 1060.27000 | |
| Density | 1.249g/cm3 | Boiling Point | 1517.336ºC at 760 mmHg | |
| Molecular Formula | C45H81N13O14S | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 871.453ºC | |
|
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.
Science 250 , 279, (1990) The amyloid beta protein is deposited in the brains of patients with Alzheimer's disease but its pathogenic role is unknown. In culture, the amyloid beta protein was neurotrophic to undifferentiated hippocampal neurons at low concentrations and neurotoxic to ... |
|
|
Methyllycaconitine alleviates amyloid-β peptides-induced cytotoxicity in SH-SY5Y cells.
PLoS ONE 9(10) , e111536, (2014) Alzheimer's disease (AD) is a chronic progressive neurodegenerative disorder. As the most common form of dementia, it affects more than 35 million people worldwide and is increasing. Excessive extracellular deposition of amyloid-β peptide (Aβ) is a pathologic... |
|
|
Mesenchymal stem cells can prevent alterations in behavior and neurogenesis induced by Aß25-35 administration.
J. Mol. Neurosci. 55(4) , 1006-13, (2015) Mesenchymal stem cells (MSCs) are known to enhance neurogenesis in the dentate gyrus, as well as to modulate immune cell activity and inflammation. Easily obtained and expanded from the bone marrow and other tissues, MSCs have been proposed as candidates for ... |